| |
|
|
|
Aequus Provides Third Quarter 2020 Financial Highlights
|
|
Vancouver, BC, December 15, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, reported financial results for the three months ended September 30, 2020 and associated Company developments.
|
|
|
|
|
|
|
|
Aequus Announces Leadership Change, Anne Stevens Stepping Down as Chief Operating Officer
|
|
Vancouver, BC, December 9, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announced that Ms Anne Stevens is stepping down from her role as Chief Operating Officer. Ms Stevens will remain a Director and will continue to serve on the Aequus Board of Directors.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aequus Provides General Update and Second Quarter 2020 Financial Highlights
|
|
Vancouver, BC, September 9, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, reported financial results for the three months ended June 30, 2020 and six months ended June 30, 2020 and associated Company developments.
|
|
|
|
|
|
|
|
Aequus Announces New Chief Commercial Officer
|
|
Vancouver, BC, August 26, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced that Grant Larsen has been appointed to the Aequus Team as Chief Commercial Officer.
|
|
|
|
|
|
|
|
Aequus Announces Positive Update on Dry Eye Product Launch Plans
|
|
Vancouver, BC, April 30, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced this week a positive update on the regulatory and launch advancement for its Evolve® line of preservative free dry eye products into Canada.
|
|
|
|
|
|
|
|
Aequus Announces Positive Update on Dry Eye Product Launch Plans
|
|
Vancouver, BC, April 22, 2020--Aequus Pharmaceuticals Inc. (TSX-V: AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced a positive update on the regulatory and launch advancement for the Evolve® line of preservative free dry eye products into Canada.
|
|
|
|
|
|
|
|
Aequus Announces Appointment of New Director to its Board & Stock Option Grant
|
|
Vancouver, BC, February 25, 2020--Aequus Pharmaceuticals Inc. (TSX-V:AQS), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced that, further to its news release on February 3, 2020, Mr. Stuart Fowler has now been formally appointed to its Board of Directors.
|
|
|
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
